Abstract
This report details the complete range of products and technologies in the
surgical management of spine disorders, diseases and trauma, from grafts,
demineralized bone, fusion, stabilization, disc/nucleus replacement,
vertebroplasty, kyphoplasty, imaging, minimally invasive surgical
technologies, energy-based therapies and biologics. The report details
current clinical and technology developments in this huge and rapidly growing
worldwide market, with data on products in development and on the market;
market size and forecast; competitor market shares; competitor profiles; and
market opportunity.
This report is a detailed market and technology assessment and forecast of the
products and technologies in the management of diseases and disorders of the
spine. The report describes diseases and disorders of the spine, encompassing
congenital disorders, inflammatory and infectious diseases; degenerative
diseases; herniations, stenoses, myelopathies and other "mechanical" disorders
of the spine; spinal trauma; tumors of the spine; and others. The report
characterizes the patient populations, their current clinical management, and
trends in clinical management as new techniques and technologies are expected
to be developed and emerge. The report details the currently available
products and technologies, and manufacturer offerings. The report details
products and technologies under development and markets for each in spine
surgery. The report provides a current and forecast assessment of the
worldwide markets for these technologies, with geographic segmentation by U.S.
& Canada, European Union (detailing France, United Kingdom, Germany, Italy and
Spain), Japan and Rest of World. The report provides emphasis on the market
impact of new technologies through the coming decade, profiling over 75 active
companies in this industry, with comprehensive detail on key companies,
providing data on their current products, current market position and products
under development.
Features:
- Worldwide scope
- Geographic segmentation
- Detailed company profiles
- Forecasts to 2017
- Competitor market shares by segment
Methodology
MedMarket Diligence Reports are produced through primary and secondary
research. Data is gathered from published sources on products and technologies
on the market and under development. Clinicians and industry representatives
are interviewed for their knowledge and insights on product development,
market development, clinical practice and trends associated with the evolving
use of technologies. Secondary data is used to corroborate and support
assessments and projections. Reports are written and researched by industry
insiders, whose familiarity with the companies, industry dynamics and other
marketplace specifics facilitate the research process and ensure high quality
and thorough reports.